We found that AS-UMOD augmentation mitigated AKI assessed by kidney function (Figure 8D), histological injury (Figure 8E), and injury-induced gene (Ngal and Spp1) expression (Figure 8F). This evidence concerns the gene LCN2 and acute kidney injury.